TIPE2 deficiency accelerates neointima formation by downregulating smooth muscle cell differentiation

Cell Cycle

Volumn 12, Issue 3, 2013, Pages 501-510

  Zhang, Guizhong ^a   Zhang, Wenqian ^a   Lou, Yunwei ^a   Xi, Wenjin ^d   Cui, Jian ^a   Geng, Minghong ^a   Zhu, Faliang ^a   Chen, Youhai H ^b   Liu, Suxia ^a,c  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SHANDONG UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Cell cycle; Phenotypic switching; TNFAIP8L2 (TIPE2); Vascular smooth muscle cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; CONTRACTILE PROTEIN; CYTOKINE; GROWTH FACTOR; IMMUNOMODULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN HEAVY CHAIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 LIKE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; MALE; MOUSE; NEOINTIMA; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

MUS;

EID: 84875500656     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23325     Document Type: Article

References (43)

1. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 2002; 8: 1249-56; PMID:12411952; http://dx.doi.org/10.1038/nm1102-1249
2. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell 2001; 104: 503-16; PMID:11239408; http://dx.doi.org/10.1016/S0092-8674(01)00238-0
3. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004; 84: 767-801; PMID:15269336; http://dx.doi.org/10.1152/physrev.00041.2003
4. Gabbiani G, Schmid E, Winter S, Chaponnier C, de Ckhastonay C, Vandekerckhove J, et al. Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. Proc Natl Acad Sci USA 1981; 78: 298-302; PMID:7017714; http://dx.doi.org/10.1073/pnas.78.1.298
5. Nagai R, Kuro-o M, Babij P, Periasamy M. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem 1989; 264: 9734-7; PMID:2722872
6. Solway J, Seltzer J, Samaha FF, Kim S, Alger LE, Niu Q, et al. Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J Biol Chem 1995; 270: 13460-9; PMID:7768949; http://dx.doi.org/10.1074/jbc.270.22.13460
7. Gimona M, Sparrow MP, Strasser P, Herzog M, Small JV. Calponin and SM 22 isoforms in avian and mammalian smooth muscle. Absence of phosphorylation in vivo. Eur J Biochem 1992; 205: 1067-75; PMID:1576991; http://dx.doi.org/10.1111/ j.1432-1033.1992. tb16875.x
8. Kusuhara M, Chait A, Cader A, Berk BC. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 1997; 17: 141-8; PMID:9012649; http://dx.doi.org/10.1161/01.ATV.17.1.141
9. Cherepanova OA, Pidkovka NA, Sarmento OF, Yoshida T, Gan Q, Adiguzel E, et al. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res 2009; 104: 609-18; PMID:19168440; http://dx.doi.org/10.1161/CIRCRESAHA.108.186064
10. Kumar MS, Owens GK. Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol 2003; 23: 737-47; PMID:12740224; http://dx.doi.org/10.1161/01. ATV.0000065197.07635.BA
11. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 2008; 133: 415-26; PMID:18455983; http://dx.doi.org/10.1016/j. cell.2008.03.026
12. Zhang G, Hao C, Lou Y, Xi W, Wang X, Wang Y, et al. Tissue-specific expression of TIPE2 provides insights into its function. Mol Immunol 2010; 47: 2435-42; PMID:20663561; http://dx.doi.org/10.1016/j.molimm.2010.06.016
13. Zhang X, Wang J, Fan C, Li H, Sun H, Gong S, et al. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat Struct Mol Biol 2009; 16: 89-90; PMID:19079267; http://dx.doi.org/10.1038/nsmb.1522
14. Zhang S, Zhang Y, Wei X, Zhen J, Wang Z, Li M, et al. Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy. Biochim Biophys Acta 2010; 1802: 1078-86; PMID:20699119; http://dx.doi.org/10.1016/j.bbadis. 2010.08.003
15. Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y, et al. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol Immunol 2011; 48: 1203-8; PMID:21466895; http://dx.doi.org/10.1016/j.molimm.2011.03.002
16. Zhang Y, Wei X, Liu L, Liu S, Wang Z, Zhang B, et al. TIPE2, a novel regulator of immunity, protects against experimental stroke. J Biol Chem 2012; 287: 32546-55; PMID:22859306; http://dx.doi.org/10.1074/jbc. M112.348755
17. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9; PMID:8479518; http://dx.doi.org/10.1038/362801a0
18. Yoshida T, Owens GK. Molecular determinants of vascular smooth muscle cell diversity. Circ Res 2005; 96: 280-91; PMID:15718508; http://dx.doi.org/10. 1161/01.RES.0000155951.62152.2e
19. Worth NF, Rolfe BE, Song J, Campbell GR. Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil Cytoskeleton 2001; 49: 130-45; PMID:11668582; http://dx.doi.org/10.1002/cm.1027
20. Gus-Brautbar Y, Johnson D, Zhang L, Sun H, Wang P, Zhang S, et al. The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell 2012; 45: 610-8; PMID:22326055; http://dx.doi.org/10.1016/j.molcel. 2012.01.006
21. Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol 2000; 190: 300-9; PMID:10685064; http://dx.doi.org/10.1002/(SICI)1096- 9896(200002)190:3<300: :AIDPATH596> 3.0.CO;2-I
22. Chen KC, Wang YS, Hu CY, Chang WC, Liao YC, Dai CY, et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J 2011; 25: 1718-28; PMID:21266537; http://dx.doi.org/10.1096/fj.10-174904
23. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 812-9; PMID:18276911; http://dx.doi.org/10.1161/ATVBAHA.107. 159327
24. Lebastchi AH, Qin L, Khan SF, Zhou J, Geirsson A, Kim RW, et al. Activation of human vascular cells decreases their expression of transforming growth factor-beta. Atherosclerosis 2011; 219: 417-24; PMID:21862019; http://dx.doi.org/10.1016/j.atherosclerosis. 2011.07.121
25. Strzalka W, Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. Ann Bot 2011; 107: 1127-40; PMID:21169293; http://dx.doi.org/10.1093/aob/mcq243
26. Hayashi K, Shibata K, Morita T, Iwasaki K, Watanabe M, Sobue K. Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. J Biol Chem 2004; 279: 40807-18; PMID:15272025; http://dx.doi.org/10. 1074/jbc. M405100200
27. Hayashi K, Takahashi M, Kimura K, Nishida W, Saga H, Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogenactivated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol 1999; 145: 727-40; PMID:10330402; http://dx.doi.org/10.1083/jcb.145.4.727
28. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, et al. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 2001; 89: 251-8; PMID:11485975; http://dx.doi.org/10.1161/hh1501.094265
29. Yoshida K, Nishida W, Hayashi K, Ohkawa Y, Ogawa A, Aoki J, et al. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 2003; 108: 1746-52; PMID:14504178; http://dx.doi.org/10.1161/01. CIR.0000089374.35455.F3
30. Sedding DG, Tröbs M, Reich F, Walker G, Fink L, Haberbosch W, et al. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling. Circ Res 2009; 104: 1192-200; PMID:19372464; http://dx.doi.org/10.1161/CIRCRESAHA.109.194357
31. Lagna G, Ku MM, Nguyen PH, Neuman NA, Davis BN, Hata A. Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors. J Biol Chem 2007; 282: 37244-55; PMID:17947237; http://dx.doi.org/10.1074/jbc.M708137200
32. Pagano PJ, Gutterman DD. The adventitia: the outs and ins of vascular disease. Cardiovasc Res 2007; 75: 636-9; PMID:17678636; http://dx.doi.org/10. 1016/j.cardiores. 2007.07.006
33. Andrés V. Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential. Cardiovasc Res 2004; 63: 11-21; PMID:15194457; http://dx.doi.org/10.1016/j. cardiores.2004.02.009
34. Su B, Mitra S, Gregg H, Flavahan S, Chotani MA, Clark KR, et al. Redox regulation of vascular smooth muscle cell differentiation. Circ Res 2001; 89: 39-46; PMID:11440976; http://dx.doi.org/10.1161/hh1301.093615
35. Pidkovka NA, Cherepanova OA, Yoshida T, Alexander MR, Deaton RA, Thomas JA, et al. Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res 2007; 101: 792-801; PMID:17704209; http://dx.doi.org/10.1161/CIRCRESAHA.107.152736
36. Mosse PR, Campbell GR, Wang ZL, Campbell JH. Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest 1985; 53: 556-62; PMID:4057952
37. Golovina VA, Blaustein MP. Preparation of primary cultured mesenteric artery smooth muscle cells for fluorescent imaging and physiological studies. Nat Protoc 2006; 1: 2681-7; PMID:17406524; http://dx.doi.org/10.1038/nprot.2006. 425
38. Ray JL, Leach R, Herbert JM, Benson M. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 2001; 23: 185-8; PMID:12486328; http://dx.doi.org/10.1023/A:1016357510143
39. Goncharova EA, Goncharov DA, Krymskaya VP. Assays for in vitro monitoring of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cell migration. Nat Protoc 2006; 1: 2933-9; PMID:17406553; http://dx.doi.org/10.1038/nprot.2006.434
40. von der Thüsen JH, van Berkel TJ, Biessen EA. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and lowdensity lipoprotein receptor-deficient mice. Circulation 2001; 103: 1164-70; PMID:11222482; http://dx.doi.org/10.1161/01.CIR.103.8.1164
41. Stein S, Matter CM. Protective roles of SIRT1 in atherosclerosis. Cell Cycle 2011; 10: 640-7; PMID:21293192; http://dx.doi.org/10.4161/cc.10.4.14863
42. Salminen A, Kaarniranta K, Kauppinen A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) 2012; 4: 166-75; PMID:22411934
43. Blagosklonny MV. Prospective treatment of agerelated diseases by slowing down aging. Am J Pathol 2012; 181: 1142-6; PMID:22841821; http://dx.doi.org/10. 1016/j.ajpath.2012.06.024